{"id":403468,"date":"2020-12-21T07:33:04","date_gmt":"2020-12-21T12:33:04","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=403468"},"modified":"2020-12-21T07:33:04","modified_gmt":"2020-12-21T12:33:04","slug":"agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/","title":{"rendered":"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">PRINCETON, N.J., Dec.  21, 2020  (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced the Company will present at the 39<sup>th<\/sup> Annual J.P. Morgan Healthcare Conference, which is being held virtually, on Thursday, January 14, 2021, at 9:10 a.m. ET.<\/p>\n<p align=\"justify\">A live webcast of the presentation will be available in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4a_qLbm_YKzz7ECgZWcPt1w2slGOgfU5lxf1O1b0E3qADqO0NxrjGUER3ESIV09H6OsV8KrYAhB3aAvgqbU4sckCkwUfjH7UN5x_DXuV-Am_8iTCl9_3C49zylVDBecR7f78SMvPP6eJXxS54f3pTA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Events and Presentations<\/a> section of the Agile Therapeutics Investor Relations page. The archived webcast will be available for 30 days.<\/p>\n<p>\n        <strong>About\u00a0Agile Therapeutics, Inc.<br \/><\/strong>Agile Therapeutics\u00a0is a women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0 Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.\u00a0 Our initial product, Twirla\u00ae, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion\u00ae, which is designed to allow drug delivery through the skin. For more information, please visit the company website at\u00a0<strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oxCm5AjKmvettvfhLeqVt0PUZ93hh5m43jBlZJQBJ8Z6fUk8Kqcfcwn70Jb2eb0xCsaCZA_-wxbnf6vHKZCNd9cRjrmdzXZF_tb5iK9oa8k=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.agiletherapeutics.com<\/a><\/strong>. The Company may occasionally disseminate material, nonpublic information on the Company\u2019s website.<\/p>\n<p>Follow Agile on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HcZCGVrGcLaOZs6DgVo_BT2DtBrohwetzka6JQWMojMuVNLxpjcyjNslC-rhgCGglBIYNNcXZUcxCW4FMab5QwM3RNEjdj_jYY-wnkIYZKLxPWOg47evzbAHxILDcWSqzbhQten7Mb7BZegp88E3hqjMYD_GYE43McQNhUbmekri44HJs05eLMOtUGROny5Io_hZ5I3yK-ila4DDDii86N1Ldt-NFR86y5fU8ORY91zH4KQMHIG5gHHdfEpSQA4Jz74580UodsNdKBixGhRJ6u9_qtwOW819WQVUSR7QKjlliS12hFtIsYV4tmdXu9_0_-FQwA_GFwIDJDUjs-k-HG1HVncBHl0C59DM0-LpZDEAcNz9N1hCHcNrdQPwfnW07YpuRXvUuIAaUwZVixNwppV7NSpBCBGbvfu-_JMq3WFoDE_jrtodjmsCWfbY9R56\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a>\u00a0and Twitter:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IBHdiFHxqeTQkK6R0flXMCHNb0A_wF9qaMXFK1Rg4eG97YpJDmRVYvshZ17S-G9N9gKWOQZFibUwUuYRbdJneU1cpmwLJ83-W-Bt5xbDsUwiaPRpapJlZXGprGF042ECQYF_hicQxZwhlYvJPSJ8xRobfELK1hFKAiQZhVaucu-gy5Uget4L86_0mQDuEDKkXgFb6-JmlalkDsj3DT5eynEYsEcC_cc5ttIyMvemqXuyOcfpbwximEEI3VoMw1_JiX7F-glgRXkgfUVapXHNnEVsR6iuIzWkE3_nWOaNQ_Cop9W-G25N8R1u2rze1iFFgKmQdEOzkeHZjmATy2Ehv2YczCO_EpnxMHoBBvoxpTy85vpCcgxz77HL7q2eZl1MdteFhRoueI4BRSK4Mt_AlSQ5KqWK2kkqmdg1i77OMPQVtrUKBney6bGyHKBeS1Jl\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>@AgileTher<\/strong><\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\u00a0\u00a0<br \/>Matt Riley<br \/>Head of Investor Relations &amp; Corporate Communications<br \/><strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5Y2DVLiYaQkIH179DL4La5x77smNcUGqdeSDaB7Gl7ESJtxvmtH75Ew0v1XNW1XDSd2a9FMZhuWDdqEHZ6pYxsOVVpMRGxZIDbauqNfxY1fI_naXgbOI0E5icULEwhmA\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mriley@agiletherapeutics.com<\/a><\/strong><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d494e76d-49b6-4b35-94f8-f7935ebd08b2\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced the Company will present at the 39th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on Thursday, January 14, 2021, at 9:10 a.m. ET. A live webcast of the presentation will be available in the Events and Presentations section of the Agile Therapeutics Investor Relations page. The archived webcast will be available for 30 days. About\u00a0Agile Therapeutics, Inc.Agile Therapeutics\u00a0is a women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0 Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.\u00a0 Our initial &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-403468","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced the Company will present at the 39th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on Thursday, January 14, 2021, at 9:10 a.m. ET. A live webcast of the presentation will be available in the Events and Presentations section of the Agile Therapeutics Investor Relations page. The archived webcast will be available for 30 days. About\u00a0Agile Therapeutics, Inc.Agile Therapeutics\u00a0is a women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0 Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.\u00a0 Our initial &hellip; Continue reading &quot;Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-21T12:33:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference\",\"datePublished\":\"2020-12-21T12:33:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/\"},\"wordCount\":213,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/\",\"name\":\"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=\",\"datePublished\":\"2020-12-21T12:33:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference - Market Newsdesk","og_description":"PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced the Company will present at the 39th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on Thursday, January 14, 2021, at 9:10 a.m. ET. A live webcast of the presentation will be available in the Events and Presentations section of the Agile Therapeutics Investor Relations page. The archived webcast will be available for 30 days. About\u00a0Agile Therapeutics, Inc.Agile Therapeutics\u00a0is a women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0 Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.\u00a0 Our initial &hellip; Continue reading \"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-21T12:33:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference","datePublished":"2020-12-21T12:33:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/"},"wordCount":213,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/","name":"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=","datePublished":"2020-12-21T12:33:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDg4NyMzODg4NzEwIzIwMDc5MTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=403468"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403468\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=403468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=403468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=403468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}